Dermatitis due to substances taken internally

L12_INTERNALSUBSTANCEDERM

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 L27
Hospital discharge: ICD-9 693
Hospital discharge: ICD-8 $!$
Hospital discharge: excluded ICD-9 L272
Cause of death: ICD-10 L27
Cause of death: ICD-9 693
Cause of death: ICD-8 $!$
Cause of death: excluded ICD-9 L272

2373

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

2278

diagram downward connector

Check minimum number of events None

2278

diagram downward connector

Include endpoints None

2278

diagram downward connector
L12_INTERNALSUBSTANCEDERM

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 L20-L30
Name in latin Dermatitis e substantiis devoratis

Similar endpoints

Summary Statistics

Key figures

All Female Male
Number of individuals 2278 1459 819
Unadjusted prevalence (%) 0.64 0.74 0.52
Mean age at first event (years) 34.69 34.61 34.82

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.42 [1.04, 5.62] 4.0e-2 169
15 years 0.01 1.03 [0.45, 2.35] 9.5e-1 56
5 years 0.00 3.49 [1.97, 6.17] 1.8e-5 57
1 year 0.00 11.54 [6.65, 20.05] 3.7e-18 37

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: L12_INTERNALSUBSTANCEDERM – Dermatitis due to substances taken internally
GWS hits: 1

Survival analyses between endpoints

Plot

before Dermatitis due to substances taken internally
after Dermatitis due to substances taken internally

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Dermatitis due to substances taken internally